CVE-2021-25921
moderate-risk
Published 2021-03-22
In OpenEMR, versions 2.7.3-rc1 to 6.0.0 are vulnerable to Stored Cross-Site-Scripting (XSS) due to user input not being validated properly in the `Allergies` section. An attacker could lure an admin to enter a malicious payload and by that initiate the exploit.
Do I need to act?
!
57.1% chance of exploitation in next 30 days
EPSS score — higher than 43% of all CVEs
-
Not on CISA KEV list
No confirmed active exploitation reported to CISA
?
Patch status unknown
Check vendor advisories for fix availability and mitigation guidance
5
CVSS 5.4/10
Medium
NETWORK
/ LOW complexity
Affected Products (1)
Affected Vendors
References (4)
Third Party Advisory
https://www.whitesourcesoftware.com/vulnerability-database/CVE-2021-25921
Third Party Advisory
https://www.whitesourcesoftware.com/vulnerability-database/CVE-2021-25921
44
/ 100
moderate-risk
Severity
21/34 · High
Exploitability
18/34 · Moderate
Exposure
5/34 · Minimal